The ZMIZ1-related DNAm status is regarded as a molecular marker in multiple cancer types, including astrocytoma, bladder cancer, and renal cell carcinoma (Mathios et al., 2019). The gene discussed is ZMIZ1; the disease is astrocytoma (excluding glioblastoma).